Aptinyx's Series A Round

Aptinyx raised a round of funding on May 10, 2016.

Aptinyx is a biopharmaceutical company focused on discovery and development of transformative therapies for challenging disorders of the brain and nervous system. Aptinyx has a proven platform for dis…

Articles about Aptinyx's Series A Round: